- Home
- UBFO vs OBIO Comparison
UBFO vs OBIO Comparison
Compare UBFO & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBFO
- OBIO
- Stock Information
- Founded
- UBFO 1987
- OBIO 2017
- Country
- UBFO United States
- OBIO United States
- Employees
- UBFO N/A
- OBIO N/A
- Industry
- UBFO Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- UBFO Finance
- OBIO Health Care
- Exchange
- UBFO Nasdaq
- OBIO Nasdaq
- Market Cap
- UBFO 154.8M
- OBIO 147.8M
- IPO Year
- UBFO N/A
- OBIO N/A
- Fundamental
- Price
- UBFO $9.35
- OBIO $2.53
- Analyst Decision
- UBFO
- OBIO Strong Buy
- Analyst Count
- UBFO 0
- OBIO 4
- Target Price
- UBFO N/A
- OBIO $14.00
- AVG Volume (30 Days)
- UBFO 15.3K
- OBIO 247.7K
- Earning Date
- UBFO 10-17-2025
- OBIO 11-11-2025
- Dividend Yield
- UBFO 5.16%
- OBIO N/A
- EPS Growth
- UBFO N/A
- OBIO N/A
- EPS
- UBFO 0.65
- OBIO N/A
- Revenue
- UBFO $44,636,000.00
- OBIO $2,944,000.00
- Revenue This Year
- UBFO N/A
- OBIO $19.83
- Revenue Next Year
- UBFO N/A
- OBIO $12.53
- P/E Ratio
- UBFO $14.37
- OBIO N/A
- Revenue Growth
- UBFO N/A
- OBIO 41.61
- 52 Week Low
- UBFO $7.32
- OBIO $2.37
- 52 Week High
- UBFO $10.49
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- UBFO 53.83
- OBIO 50.08
- Support Level
- UBFO $9.41
- OBIO N/A
- Resistance Level
- UBFO $9.65
- OBIO $2.79
- Average True Range (ATR)
- UBFO 0.17
- OBIO 0.12
- MACD
- UBFO -0.03
- OBIO -0.10
- Stochastic Oscillator
- UBFO 27.91
- OBIO 84.05
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.